Dyne Therapeutics, Inc. (DYN) stock
DYNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$16.02−0.68 (-4.07%)
Close on Nov 17, 2026Market cap $2.99BP/E –Yield –
Dyne Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Dyne Therapeutics's price to book ratio was 4.2× on Nov 11, 2026, against 4.5× a year earlier. Over the last 5 years it ranged from 0.7× to 19.1×, with a median of 3.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.2× | +0.2 |
| 2025 | Dec 31, 2025 | 4.0× | +0.6 |
| 2024 | Dec 31, 2024 | 3.4× | −2.0 |
| 2023 | Dec 29, 2023 | 5.4× | +3.0 |
| 2022 | Dec 30, 2022 | 2.4× | +0.9 |
| 2021 | Dec 31, 2021 | 1.5× | −1.1 |
| 2020 | Dec 31, 2020 | 2.6× | – |
See a number that looks wrong?